Moreover, the serum protein biomarker CCL11 (eotaxin-1), a potent chemotactic agent for basophils, is elevated in individuals with prostate cancer (30), highlighting its role in regulating immune responses and advancing tumor progression. This evidence concerns the gene CCL11 and prostate carcinoma.